Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is 0.00% as of the fiscal period ended Friday, July 31, 2026.
Reported quarterly gross margin; no daily interpolation. Q3 FY2026 (2026-07-31): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
0.00%
GROSS MARGIN AVG 5Y
0.00%
GROSS MARGIN AVG 10Y
0.00%
GROSS MARGIN AVG 15Y
6.64%
GROSS MARGIN AVG 20Y
32.14%
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
-100.00%
CURRENT VS 20Y AVG
-100.00%
SECTOR MEDIAN · HEALTHCARE
46.31%
median of 426 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Anixa Biosciences, Inc.
Market Cap
$100.37M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$104.07M
Gross Margin
71.67%
TTM Avg
77.09%
3Y Avg
79.04%
5Y Avg
77.65%
Market Cap
$106.23M
Gross Margin
83.37%
TTM Avg
83.81%
3Y Avg
82.64%
5Y Avg
80.50%
Market Cap
$108.39M
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
2.35%
Market Cap
$91.33M
Gross Margin
87.06%
TTM Avg
85.86%
3Y Avg
83.85%
5Y Avg
76.72%
Market Cap
$109.49M
Gross Margin
33.94%
TTM Avg
48.53%
3Y Avg
56.75%
5Y Avg
59.91%
Market Cap
$111.17M
Gross Margin
99.54%
TTM Avg
49.77%
3Y Avg
24.89%
5Y Avg
16.59%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Anixa Biosciences, Inc. (ANIX) | $100.37M | 0.00% | 0.00% | 0.00% | 0.00% |
| Definitive Healthcare Corp. (DH)vs › | $104.07M | 71.67% | 77.09% | 79.04% | 77.65% |
| Cumberland Pharmaceuticals Inc. (CPIX)vs › | $106.23M | 83.37% | 83.81% | 82.64% | 80.50% |
| Biomea Fusion, Inc. (BMEA)vs › | $93.99M | 0.00% | 0.00% | 0.00% | 0.00% |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP)vs › | $108.39M | 0.00% | 0.00% | 0.00% | 2.35% |
| Equillium, Inc. (EQ)vs › | $91.68M | 0.00% | 50.00% | 75.00% | 50.00% |
| electroCore, Inc. (ECOR)vs › | $91.33M | 87.06% | 85.86% | 83.85% | 76.72% |
| Apyx Medical Corporation (APYX)vs › | $109.49M | 33.94% | 48.53% | 56.75% | 59.91% |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $111.17M | 99.54% | 49.77% | 24.89% | 16.59% |
| ImmuCell Corporation (ICCC)vs › | $88.21M | 40.32% | 35.69% | 34.43% | 37.90% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-07-31 | 0.00% |
| 2026-04-30 | 0.00% |
| 2026-01-31 | 0.00% |
| 2025-10-31 | 0.00% |
| 2025-07-31 | 0.00% |
| 2025-04-30 | 0.00% |
| 2025-01-31 | 0.00% |
| 2024-10-31 | 0.00% |
| 2024-07-31 | 0.00% |
| 2024-04-30 | 0.00% |
| 2024-01-31 | 0.00% |
| 2023-10-31 | 0.00% |
| 2023-07-31 | 0.00% |
| 2023-04-30 | 23.33% |
| 2023-01-31 | 0.00% |
| 2022-10-31 | 0.00% |
| 2022-07-31 | 0.00% |
| 2022-04-30 | 0.00% |
| 2022-01-31 | 0.00% |
| 2021-10-31 | 0.00% |
| 2021-07-31 | 0.00% |
| 2021-04-30 | 0.00% |
| 2021-01-31 | 24.95% |
| 2020-10-31 | 0.00% |
| 2020-07-31 | 0.00% |
| 2020-04-30 | 0.00% |
| 2020-01-31 | 0.00% |
| 2019-10-31 | 0.00% |
| 2019-07-31 | 0.00% |
| 2019-04-30 | 33.50% |
| 2019-01-31 | 0.00% |
| 2018-10-31 | 0.00% |
| 2018-07-31 | 33.47% |
| 2018-04-30 | 33.24% |
| 2018-01-31 | 0.00% |
| 2017-10-31 | 0.00% |
| 2017-07-31 | 61.07% |
| 2017-04-30 | 0.00% |
| 2017-01-31 | 0.00% |
| 2016-10-31 | 64.01% |
| 2016-07-31 | 29.73% |
| 2016-04-30 | 0.00% |
| 2016-01-31 | 0.00% |
| 2015-10-31 | 0.00% |
| 2015-07-31 | 14.15% |
| 2015-04-30 | -382.55% |
| 2015-01-31 | 62.52% |
| 2014-10-31 | 8.62% |
| 2014-07-31 | 86.31% |
| 2014-04-30 | 51.50% |
| 2014-01-31 | 0.00% |
| 2013-10-31 | 25.12% |
| 2013-07-31 | 0.00% |
| 2013-04-30 | 0.00% |
| 2013-01-31 | 0.00% |
| 2012-10-31 | -450.00% |
| 2012-07-31 | 99.71% |
| 2012-04-30 | 99.80% |
| 2012-01-31 | 99.84% |
| 2011-10-31 | 99.87% |
| 2011-07-31 | 99.19% |
| 2011-04-30 | 71.64% |
| 2011-01-31 | 69.30% |
| 2010-10-31 | 97.67% |
| 2010-07-31 | 41.40% |
| 2010-04-30 | 94.10% |
| 2010-01-31 | 43.38% |
| 2009-10-31 | 94.04% |
| 2009-07-31 | -128.16% |
| 2009-04-30 | 98.44% |
| 2009-01-31 | 94.76% |
| 2008-10-31 | 98.89% |
| 2008-07-31 | 96.07% |
| 2008-04-30 | 77.46% |
| 2008-01-31 | 75.30% |
| 2007-10-31 | 68.01% |
| 2007-07-31 | 67.58% |
| 2007-04-30 | 63.07% |
| 2007-01-31 | 68.49% |
| 2006-10-31 | 67.63% |
| 2006-07-31 | 70.01% |
| 2006-04-30 | 63.86% |
| 2006-01-31 | 71.62% |
| 2005-10-31 | -239.89% |
| 2005-07-31 | -168.55% |
| 2005-04-30 | -190.86% |
| 2005-01-31 | 69.63% |
| 2004-10-31 | 66.04% |
| 2004-07-31 | 61.55% |
| 2004-04-30 | 68.86% |
| 2004-01-31 | 62.57% |
| 2003-10-31 | -41.47% |
| 2003-07-31 | 63.36% |
| 2003-04-30 | 27.98% |
| 2003-01-31 | 32.09% |
| 2002-10-31 | -182.06% |
